Saturday, Jan 28, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Top Section | More Covid Vaccines In Pipeline

More Covid vaccines in pipeline

At least four to five more candidates in advanced stages of clinical trials and expected to get a nod from regulatory authorities

By M. Sai Gopal
Updated On - 01:18 AM, Fri - 5 March 21
More Covid vaccines in pipeline
So far, 49,762 individuals from the priority age groups have been vaccinated in Telangana.

Hyderabad: The year 2020 was all about lockdowns, understanding the SARS-CoV-2, preparing and fighting the pandemic. While Covid-19 continues to remain active, the year 2021, however, is definitely all about getting vaccinated in large numbers and put an end to the pandemic quickly. Apart from the existing two vaccines i.e. Covidshield by Serum Institute and Covaxin from Bharat Biotech, there are at least four to five more vaccine candidates that are in advanced stages of clinical trials and are expected to get a nod from the regulatory authorities in the coming days.

ZyCoV-D

Under development by Ahmedabad-based Zydus-Cadilla, this potential vaccine is undergoing phase III clinical trials at 50 multiple centres across the country. The company has recruited 28,216 individuals aged between 12 years and 99 years for the phase III trials. The phase I and phase II human trials are already over.

Sputnik

The Hyderabad-based Dr Reddy’s Laboratories is collaborating with the Russian vaccine firm and are jointly conducting phase II and III clinical trials to assess the safety and immunogenicity of Sputnik vaccine. The phase III clinical trials are already underway at 25 sites across India with 1,500 to 2,000 volunteers participating in it. The Sputnik vaccine efficacy results, which were published in The Lancet, were close to 92 per cent.

Biological E Ltd

The Hyderabad-based Biological-E Ltd is undertaking phase I and II human clinical trials for its proposed Covid vaccine candidates. The phase I and II clinical trials are underway at five different locations on a sample size of 360 to 400 participants. The Biological E Ltd is collaborating with Dynavax Technologies Corporation, a US-based biopharma company and Baylor College of Medicine from Texas, and has received approval from Drugs Controller General of India (DCGI). The results of phase I and II are expected in the coming days.

Indian Immunologicals Ltd

Another top Hyderabad-based animal and human-based pharmaceutical company, IIL is preparing ground and is reportedly in talks with US-based Moderna for a possible technology transfer of the Moderna Covid vaccine to India. Along with Pfizer, the Moderna vaccine was amongst the first vaccines that displayed 90 per cent efficacy against the virus.

Gennova Covid vaccine

The Department of Biotechnology (DBT), Government of India is collaborating with Pune-based Gennova Pharmaceuticals to develop an RNA based vaccine, on the lines of the vaccine developed by Pfizer. The company is undertaking phase I and II trials and reportedly will soon take up phase III trials. Unlike Pfizer vaccine, which has to be maintained at extremely cold temperatures, the Gennovo vaccine can be stored in a normal fridge.

Also read:

54 per cent of Hyderabad’s population developed antibodies against Covid-19: Study

COVID-19 vaccination: 21,207 inoculated in Telangana

Covid-19: 152 new cases and two fatalities in Telangana


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


 

  • Follow Us :
  • Tags
  • Biological E Ltd
  • Covid vaccines
  • Gennova Covid vaccine
  • Indian Immunologicals Ltd

Related News

  • Editorial: Monumental failure

    Editorial: Monumental failure

  • Health Ministry must allow booster doses for eligible at all Govt Hospitals: Telangana

    Health Ministry must allow booster doses for eligible at all Govt Hospitals: Telangana

  • Severe obesity blunts antibody response to Covid vaccines: Study

    Severe obesity blunts antibody response to Covid vaccines: Study

  • Covid mRNA tech may create first-ever cure for heart attacks

    Covid mRNA tech may create first-ever cure for heart attacks

  • Telangana administers Covid vaccines to 100 per cent eligible beneficiaries above 18

    Telangana administers Covid vaccines to 100 per cent eligible beneficiaries above 18

  • 6 cr Covid vaccine doses administered in Telangana so far

    6 cr Covid vaccine doses administered in Telangana so far

Latest News

  • NASA’s mega Moon rocket now ready for crewed mission

    11 mins ago
  • BharatPe paid Rs 1.69 cr salary to Ashneer in FY22, Rs 63 lakh to his wife

    26 mins ago
  • Twitter will take ‘less severe action’ against accounts that break rules

    41 mins ago
  • Complaint against RSS chief for outraging religious sentiments of Hindus

    57 mins ago
  • PM Modi in Rajasthan, will offer prayers at Malaseri Dungri

    1 hour ago
  • “Stay away from politics,” Kangana Ranaut warns Bollywood over usage of “triumph over hate”

    1 hour ago
  • Man City beat Arsenal 1-0 to reach FA Cup fifth round

    1 hour ago
  • Kharge writes to Shah, seeks his intervention in ensuring adequate security for Bharat Jodo Yatra in J-K 

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam